跳至主要内容
临床试验/NCT05998811
NCT05998811尚未招募不适用

Exploring Uterine Cancer Clinical Trials - Revealing Participation Patterns in Individuals With Uterine Cancer

Power Life Sciences Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年9月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Rate of patients who remain in a uterine cancer clinical trial to trial completion

研究概览

简要总结

Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
  • Diagnosis of uterine cancer
  • No prior treatment for uterine cancer

排除标准

  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
  • Enrolled in another research study
  • Inability to provide written informed consent

结局指标

主要结局

Rate of patients who remain in a uterine cancer clinical trial to trial completion

时间窗: 12 months

Number of patients who decide to enroll in a uterine cancer clinical research

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验